Delwyn Catley
Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 51 | 2023 | 75 | 12.560 |
Why?
| Smoking | 38 | 2021 | 69 | 8.940 |
Why?
| Motivational Interviewing | 20 | 2021 | 52 | 7.610 |
Why?
| Motivation | 31 | 2021 | 64 | 4.330 |
Why?
| Humans | 100 | 2023 | 6599 | 3.130 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2023 | 44 | 3.120 |
Why?
| Female | 75 | 2023 | 3436 | 2.650 |
Why?
| Male | 75 | 2023 | 3197 | 2.620 |
Why?
| Health Education | 7 | 2021 | 39 | 2.530 |
Why?
| Adult | 53 | 2023 | 1233 | 2.460 |
Why?
| Middle Aged | 41 | 2020 | 648 | 2.290 |
Why?
| Tobacco Use Disorder | 15 | 2020 | 19 | 2.280 |
Why?
| Intention | 6 | 2021 | 24 | 2.120 |
Why?
| Commerce | 3 | 2020 | 6 | 2.030 |
Why?
| Counseling | 16 | 2020 | 60 | 1.990 |
Why?
| Medication Adherence | 10 | 2020 | 59 | 1.940 |
Why?
| Tobacco Use | 3 | 2021 | 3 | 1.790 |
Why?
| Students | 13 | 2021 | 43 | 1.760 |
Why?
| Text Messaging | 5 | 2023 | 15 | 1.700 |
Why?
| Life Style | 6 | 2023 | 32 | 1.590 |
Why?
| Multiple Sclerosis, Relapsing-Remitting | 4 | 2019 | 8 | 1.570 |
Why?
| Health Promotion | 6 | 2022 | 50 | 1.430 |
Why?
| Minors | 2 | 2020 | 2 | 1.410 |
Why?
| Health Behavior | 12 | 2023 | 72 | 1.370 |
Why?
| Developing Countries | 4 | 2023 | 14 | 1.370 |
Why?
| Health Knowledge, Attitudes, Practice | 7 | 2021 | 80 | 1.180 |
Why?
| Community Health Workers | 2 | 2023 | 6 | 1.150 |
Why?
| Adolescent | 21 | 2021 | 2087 | 1.130 |
Why?
| United States | 16 | 2022 | 646 | 1.100 |
Why?
| Decision Making | 5 | 2021 | 34 | 1.080 |
Why?
| Patient Acceptance of Health Care | 5 | 2021 | 44 | 1.070 |
Why?
| Cost-Benefit Analysis | 4 | 2023 | 36 | 1.060 |
Why?
| Telemedicine | 4 | 2022 | 64 | 1.050 |
Why?
| Cardiovascular Diseases | 3 | 2022 | 49 | 1.030 |
Why?
| Young Adult | 21 | 2021 | 652 | 1.030 |
Why?
| Patient Selection | 5 | 2019 | 40 | 0.980 |
Why?
| Attitude to Health | 6 | 2019 | 35 | 0.950 |
Why?
| Analgesics, Opioid | 2 | 2020 | 44 | 0.930 |
Why?
| South Africa | 4 | 2023 | 16 | 0.880 |
Why?
| HIV Infections | 7 | 2020 | 140 | 0.870 |
Why?
| Tobacco Products | 2 | 2020 | 3 | 0.830 |
Why?
| Treatment Outcome | 12 | 2022 | 624 | 0.790 |
Why?
| Tobacco Use Cessation | 1 | 2020 | 2 | 0.790 |
Why?
| Hospitalists | 1 | 2020 | 9 | 0.780 |
Why?
| Depression | 5 | 2021 | 68 | 0.770 |
Why?
| Adaptation, Psychological | 2 | 2018 | 41 | 0.770 |
Why?
| Drug Prescriptions | 1 | 2020 | 22 | 0.770 |
Why?
| Multiple Sclerosis | 5 | 2018 | 18 | 0.770 |
Why?
| Medicaid | 1 | 2020 | 37 | 0.750 |
Why?
| Residence Characteristics | 1 | 2020 | 43 | 0.750 |
Why?
| Guideline Adherence | 1 | 2020 | 33 | 0.750 |
Why?
| Socioeconomic Factors | 6 | 2017 | 63 | 0.750 |
Why?
| Patient Compliance | 8 | 2017 | 70 | 0.740 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 82 | 0.720 |
Why?
| Behavior Therapy | 2 | 2019 | 41 | 0.720 |
Why?
| Delivery of Health Care | 1 | 2019 | 29 | 0.690 |
Why?
| Surveys and Questionnaires | 14 | 2019 | 290 | 0.690 |
Why?
| Attitude of Health Personnel | 5 | 2015 | 49 | 0.660 |
Why?
| Aged | 9 | 2022 | 375 | 0.650 |
Why?
| Child | 10 | 2021 | 3146 | 0.640 |
Why?
| Executive Function | 1 | 2017 | 11 | 0.610 |
Why?
| Cross-Sectional Studies | 6 | 2021 | 317 | 0.610 |
Why?
| Interviews as Topic | 5 | 2013 | 36 | 0.600 |
Why?
| Bupropion | 8 | 2005 | 11 | 0.560 |
Why?
| Treatment Refusal | 1 | 2015 | 6 | 0.550 |
Why?
| Antirheumatic Agents | 1 | 2015 | 14 | 0.550 |
Why?
| Physician-Patient Relations | 2 | 2021 | 24 | 0.540 |
Why?
| Severity of Illness Index | 1 | 2015 | 142 | 0.520 |
Why?
| Universities | 7 | 2017 | 14 | 0.520 |
Why?
| Kansas | 5 | 2021 | 49 | 0.480 |
Why?
| Anti-HIV Agents | 4 | 2019 | 36 | 0.470 |
Why?
| Randomized Controlled Trials as Topic | 7 | 2020 | 62 | 0.430 |
Why?
| Patient Participation | 3 | 2021 | 21 | 0.410 |
Why?
| Urban Population | 4 | 2019 | 36 | 0.390 |
Why?
| Patient Education as Topic | 6 | 2019 | 64 | 0.380 |
Why?
| Education, Pharmacy | 1 | 2010 | 2 | 0.380 |
Why?
| Students, Pharmacy | 1 | 2010 | 2 | 0.380 |
Why?
| Educational Measurement | 1 | 2010 | 7 | 0.380 |
Why?
| United States Food and Drug Administration | 2 | 2020 | 6 | 0.350 |
Why?
| Adolescent Behavior | 2 | 2021 | 47 | 0.350 |
Why?
| Models, Statistical | 3 | 2018 | 34 | 0.340 |
Why?
| Behavior Control | 1 | 2008 | 2 | 0.330 |
Why?
| Telephone | 4 | 2017 | 12 | 0.330 |
Why?
| Censuses | 2 | 2018 | 3 | 0.330 |
Why?
| Time Factors | 5 | 2017 | 241 | 0.330 |
Why?
| Demography | 2 | 2018 | 10 | 0.330 |
Why?
| Antiretroviral Therapy, Highly Active | 2 | 2020 | 12 | 0.320 |
Why?
| Rural Population | 3 | 2019 | 38 | 0.320 |
Why?
| Immunosuppressive Agents | 2 | 2019 | 37 | 0.320 |
Why?
| Self Efficacy | 5 | 2014 | 28 | 0.320 |
Why?
| Curriculum | 2 | 2020 | 19 | 0.310 |
Why?
| Delay Discounting | 2 | 2018 | 2 | 0.310 |
Why?
| Nicotine | 3 | 2005 | 11 | 0.310 |
Why?
| Primary Health Care | 2 | 2019 | 44 | 0.300 |
Why?
| Dopamine Uptake Inhibitors | 6 | 2005 | 6 | 0.280 |
Why?
| Emergency Service, Hospital | 3 | 2021 | 129 | 0.270 |
Why?
| Aftercare | 2 | 2023 | 6 | 0.270 |
Why?
| Feasibility Studies | 6 | 2021 | 66 | 0.270 |
Why?
| Religion | 3 | 2019 | 10 | 0.260 |
Why?
| Dental Hygienists | 2 | 2015 | 2 | 0.260 |
Why?
| Retrospective Studies | 5 | 2021 | 1251 | 0.260 |
Why?
| Clinical Competence | 3 | 2020 | 32 | 0.250 |
Why?
| Program Evaluation | 3 | 2020 | 52 | 0.240 |
Why?
| Pilot Projects | 4 | 2021 | 124 | 0.240 |
Why?
| Child, Hospitalized | 2 | 2020 | 27 | 0.240 |
Why?
| Professional-Patient Relations | 3 | 2015 | 8 | 0.240 |
Why?
| Affect | 3 | 2015 | 11 | 0.240 |
Why?
| Urban Health | 3 | 2021 | 5 | 0.230 |
Why?
| Follow-Up Studies | 5 | 2015 | 315 | 0.230 |
Why?
| Protestantism | 2 | 2020 | 6 | 0.230 |
Why?
| Weight Loss | 2 | 2022 | 39 | 0.230 |
Why?
| Reward | 2 | 2016 | 7 | 0.220 |
Why?
| Diabetes Mellitus | 2 | 2020 | 21 | 0.220 |
Why?
| Triglycerides | 1 | 2022 | 20 | 0.210 |
Why?
| Community-Institutional Relations | 2 | 2019 | 9 | 0.210 |
Why?
| Mass Screening | 2 | 2020 | 41 | 0.210 |
Why?
| Medical Marijuana | 1 | 2021 | 1 | 0.210 |
Why?
| Cannabis | 1 | 2021 | 3 | 0.210 |
Why?
| Rural Health | 1 | 2021 | 3 | 0.200 |
Why?
| Patient Satisfaction | 3 | 2015 | 41 | 0.200 |
Why?
| Adolescent Health Services | 1 | 2021 | 14 | 0.200 |
Why?
| Consumer Behavior | 1 | 2021 | 4 | 0.200 |
Why?
| Sexual Behavior | 1 | 2021 | 40 | 0.200 |
Why?
| Psychiatric Status Rating Scales | 2 | 2018 | 16 | 0.200 |
Why?
| Oral Hygiene | 1 | 2020 | 3 | 0.200 |
Why?
| Tobacco, Smokeless | 1 | 2020 | 1 | 0.190 |
Why?
| Marketing | 1 | 2020 | 2 | 0.190 |
Why?
| Referral and Consultation | 2 | 2022 | 33 | 0.190 |
Why?
| Double-Blind Method | 9 | 2005 | 48 | 0.190 |
Why?
| Prefrontal Cortex | 1 | 2020 | 5 | 0.190 |
Why?
| Caregivers | 1 | 2020 | 38 | 0.190 |
Why?
| Risk Reduction Behavior | 1 | 2020 | 14 | 0.190 |
Why?
| Regression Analysis | 3 | 2017 | 56 | 0.180 |
Why?
| Migraine Disorders | 1 | 2020 | 16 | 0.180 |
Why?
| Brain | 1 | 2020 | 74 | 0.180 |
Why?
| Magnetic Resonance Imaging | 1 | 2020 | 114 | 0.180 |
Why?
| Psychometrics | 2 | 2017 | 33 | 0.180 |
Why?
| Combined Modality Therapy | 2 | 2017 | 51 | 0.180 |
Why?
| Drug-Eluting Stents | 1 | 2019 | 2 | 0.170 |
Why?
| Percutaneous Coronary Intervention | 1 | 2019 | 2 | 0.170 |
Why?
| Nicotinic Agonists | 2 | 2017 | 4 | 0.170 |
Why?
| Decision Support Techniques | 1 | 2019 | 9 | 0.170 |
Why?
| Internal-External Control | 2 | 2009 | 4 | 0.170 |
Why?
| Clinical Decision-Making | 1 | 2019 | 20 | 0.170 |
Why?
| Evidence-Based Medicine | 1 | 2019 | 43 | 0.170 |
Why?
| Infant | 2 | 2020 | 1396 | 0.170 |
Why?
| Communication | 3 | 2015 | 54 | 0.170 |
Why?
| Child, Preschool | 2 | 2020 | 1459 | 0.170 |
Why?
| Prospective Studies | 2 | 2017 | 508 | 0.170 |
Why?
| Public Policy | 1 | 2017 | 1 | 0.160 |
Why?
| Awareness | 1 | 2017 | 5 | 0.160 |
Why?
| Religion and Medicine | 1 | 2017 | 4 | 0.160 |
Why?
| Stress, Psychological | 3 | 2007 | 33 | 0.160 |
Why?
| Qualitative Research | 2 | 2015 | 34 | 0.160 |
Why?
| Algorithms | 1 | 2018 | 103 | 0.160 |
Why?
| Infant, Newborn | 1 | 2020 | 790 | 0.150 |
Why?
| Inpatients | 1 | 2017 | 44 | 0.150 |
Why?
| Substance-Related Disorders | 2 | 2018 | 32 | 0.150 |
Why?
| Choice Behavior | 1 | 2016 | 6 | 0.150 |
Why?
| Methadone | 2 | 2007 | 2 | 0.140 |
Why?
| Narcotics | 2 | 2007 | 7 | 0.140 |
Why?
| Self Concept | 2 | 2015 | 12 | 0.140 |
Why?
| Teaching | 2 | 2013 | 4 | 0.130 |
Why?
| Faculty | 2 | 2013 | 4 | 0.130 |
Why?
| Directly Observed Therapy | 1 | 2013 | 5 | 0.120 |
Why?
| Reproducibility of Results | 4 | 2019 | 197 | 0.110 |
Why?
| Emotions | 2 | 2011 | 23 | 0.110 |
Why?
| Varenicline | 1 | 2012 | 4 | 0.110 |
Why?
| Quinoxalines | 1 | 2012 | 4 | 0.110 |
Why?
| Benzazepines | 1 | 2012 | 6 | 0.110 |
Why?
| Nicotinic Antagonists | 1 | 2012 | 9 | 0.110 |
Why?
| Patient Discharge | 2 | 2023 | 58 | 0.110 |
Why?
| Cues | 1 | 2011 | 5 | 0.100 |
Why?
| Comorbidity | 2 | 2014 | 61 | 0.100 |
Why?
| Social Environment | 1 | 2011 | 9 | 0.100 |
Why?
| Psychology | 1 | 2010 | 6 | 0.090 |
Why?
| Self Report | 2 | 2021 | 43 | 0.090 |
Why?
| Social Support | 2 | 2012 | 38 | 0.090 |
Why?
| Self Disclosure | 1 | 2009 | 6 | 0.090 |
Why?
| Health Surveys | 1 | 2009 | 15 | 0.090 |
Why?
| HIV Seropositivity | 1 | 2009 | 8 | 0.090 |
Why?
| Psychological Tests | 2 | 2011 | 6 | 0.090 |
Why?
| Poverty | 2 | 2006 | 28 | 0.090 |
Why?
| Aged, 80 and over | 2 | 2020 | 150 | 0.080 |
Why?
| Computers, Handheld | 1 | 2008 | 11 | 0.080 |
Why?
| Probability | 2 | 2018 | 17 | 0.080 |
Why?
| Research Design | 3 | 2017 | 64 | 0.080 |
Why?
| Missouri | 2 | 2019 | 78 | 0.080 |
Why?
| Recurrence | 2 | 2018 | 115 | 0.080 |
Why?
| Anti-Retroviral Agents | 2 | 2020 | 18 | 0.080 |
Why?
| Sleep | 1 | 2007 | 36 | 0.080 |
Why?
| Pain | 1 | 2007 | 53 | 0.070 |
Why?
| Administration, Cutaneous | 2 | 2004 | 6 | 0.070 |
Why?
| Interview, Psychological | 1 | 2006 | 3 | 0.070 |
Why?
| Chewing Gum | 1 | 2006 | 1 | 0.070 |
Why?
| Personal Autonomy | 2 | 2019 | 4 | 0.070 |
Why?
| Program Development | 2 | 2017 | 16 | 0.070 |
Why?
| Cohort Studies | 2 | 2018 | 264 | 0.070 |
Why?
| Mental Health Services | 1 | 2005 | 3 | 0.070 |
Why?
| Oral Health | 2 | 2015 | 2 | 0.060 |
Why?
| Sexuality | 2 | 2015 | 4 | 0.060 |
Why?
| Poverty Areas | 1 | 2003 | 5 | 0.060 |
Why?
| Tobacco Smoke Pollution | 1 | 2003 | 6 | 0.060 |
Why?
| Menthol | 1 | 2003 | 1 | 0.060 |
Why?
| Obesity | 1 | 2005 | 124 | 0.060 |
Why?
| Minority Groups | 1 | 2003 | 18 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2003 | 44 | 0.060 |
Why?
| Bayes Theorem | 1 | 2023 | 30 | 0.060 |
Why?
| Organizations | 1 | 2022 | 1 | 0.060 |
Why?
| Health Status | 2 | 2017 | 28 | 0.060 |
Why?
| Random Allocation | 1 | 2022 | 7 | 0.050 |
Why?
| Informed Consent | 1 | 2022 | 5 | 0.050 |
Why?
| Gender Identity | 1 | 2021 | 4 | 0.050 |
Why?
| Legislation, Drug | 1 | 2021 | 2 | 0.050 |
Why?
| Health Personnel | 1 | 2021 | 28 | 0.050 |
Why?
| Registries | 1 | 2021 | 85 | 0.050 |
Why?
| Midwestern United States | 2 | 2011 | 39 | 0.050 |
Why?
| Medicare | 1 | 2020 | 3 | 0.050 |
Why?
| Mexico | 1 | 2020 | 6 | 0.050 |
Why?
| Incidence | 1 | 2020 | 125 | 0.050 |
Why?
| Sex Factors | 2 | 2014 | 71 | 0.050 |
Why?
| Hospitalization | 1 | 2021 | 192 | 0.040 |
Why?
| Language | 1 | 2019 | 6 | 0.040 |
Why?
| Prosthesis Design | 1 | 2019 | 9 | 0.040 |
Why?
| Patient Preference | 1 | 2019 | 6 | 0.040 |
Why?
| Hospitals, Pediatric | 1 | 2020 | 178 | 0.040 |
Why?
| Religious Personnel | 1 | 2019 | 3 | 0.040 |
Why?
| Serologic Tests | 1 | 2019 | 6 | 0.040 |
Why?
| Social Stigma | 1 | 2019 | 16 | 0.040 |
Why?
| Disability Evaluation | 1 | 2017 | 10 | 0.040 |
Why?
| Analysis of Variance | 1 | 2017 | 24 | 0.040 |
Why?
| Health Priorities | 1 | 2017 | 3 | 0.040 |
Why?
| Area Under Curve | 1 | 2017 | 34 | 0.040 |
Why?
| Community-Based Participatory Research | 1 | 2017 | 10 | 0.040 |
Why?
| Longitudinal Studies | 1 | 2018 | 123 | 0.040 |
Why?
| Needs Assessment | 1 | 2017 | 21 | 0.040 |
Why?
| Feeding Behavior | 2 | 2010 | 51 | 0.040 |
Why?
| Risk Assessment | 1 | 2018 | 130 | 0.040 |
Why?
| Health Status Disparities | 1 | 2017 | 22 | 0.040 |
Why?
| Tertiary Care Centers | 1 | 2017 | 10 | 0.040 |
Why?
| Stroke | 1 | 2017 | 24 | 0.040 |
Why?
| Cognition | 1 | 2017 | 30 | 0.040 |
Why?
| Disease Progression | 1 | 2017 | 104 | 0.040 |
Why?
| Clinical Protocols | 1 | 2017 | 35 | 0.040 |
Why?
| Risk Factors | 1 | 2018 | 460 | 0.040 |
Why?
| Patient Care Planning | 1 | 2015 | 2 | 0.030 |
Why?
| Interprofessional Relations | 1 | 2015 | 6 | 0.030 |
Why?
| Health Care Costs | 1 | 2015 | 29 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2015 | 38 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2015 | 96 | 0.030 |
Why?
| Greece | 1 | 2014 | 1 | 0.030 |
Why?
| Prevalence | 1 | 2015 | 145 | 0.030 |
Why?
| Perception | 1 | 2014 | 9 | 0.030 |
Why?
| Risk | 1 | 2014 | 40 | 0.030 |
Why?
| Cotinine | 1 | 2014 | 5 | 0.030 |
Why?
| Feedback | 1 | 2013 | 7 | 0.030 |
Why?
| Age Factors | 1 | 2014 | 203 | 0.030 |
Why?
| Binge Drinking | 1 | 2012 | 2 | 0.030 |
Why?
| Data Collection | 1 | 2012 | 32 | 0.030 |
Why?
| Audiovisual Aids | 1 | 2012 | 4 | 0.030 |
Why?
| Electronics, Medical | 1 | 2012 | 5 | 0.030 |
Why?
| Health Resources | 1 | 2012 | 17 | 0.030 |
Why?
| Drug Monitoring | 1 | 2012 | 19 | 0.030 |
Why?
| Social Behavior | 1 | 2011 | 12 | 0.020 |
Why?
| Patient Dropouts | 1 | 2010 | 3 | 0.020 |
Why?
| Reminder Systems | 1 | 2010 | 5 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2010 | 34 | 0.020 |
Why?
| Logistic Models | 1 | 2010 | 91 | 0.020 |
Why?
| Montana | 1 | 2009 | 1 | 0.020 |
Why?
| Periodicity | 1 | 2009 | 3 | 0.020 |
Why?
| Personality Inventory | 1 | 2009 | 2 | 0.020 |
Why?
| Models, Psychological | 1 | 2009 | 8 | 0.020 |
Why?
| Self Care | 1 | 2009 | 24 | 0.020 |
Why?
| Social Perception | 1 | 2008 | 3 | 0.020 |
Why?
| Arthritis, Rheumatoid | 1 | 2007 | 9 | 0.020 |
Why?
| Self Administration | 1 | 2007 | 3 | 0.020 |
Why?
| Fibromyalgia | 1 | 2007 | 5 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2007 | 19 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2007 | 40 | 0.020 |
Why?
| Empathy | 1 | 2006 | 3 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2006 | 26 | 0.020 |
Why?
| Administration, Topical | 1 | 2005 | 6 | 0.020 |
Why?
| Diet, Reducing | 1 | 2005 | 6 | 0.020 |
Why?
| Placebos | 1 | 2005 | 6 | 0.020 |
Why?
| Attitude | 1 | 2005 | 12 | 0.020 |
Why?
| Body Weight | 1 | 2005 | 49 | 0.020 |
Why?
| Sex Characteristics | 1 | 2004 | 13 | 0.020 |
Why?
| Diet | 1 | 2005 | 54 | 0.020 |
Why?
| Likelihood Functions | 1 | 2004 | 6 | 0.020 |
Why?
| Factor Analysis, Statistical | 1 | 2004 | 24 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2004 | 74 | 0.020 |
Why?
| Body Mass Index | 1 | 2005 | 155 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2004 | 99 | 0.020 |
Why?
| Drug Interactions | 1 | 2003 | 30 | 0.010 |
Why?
| Eligibility Determination | 1 | 2003 | 1 | 0.010 |
Why?
| Odds Ratio | 1 | 2003 | 53 | 0.010 |
Why?
| Costs and Cost Analysis | 1 | 2003 | 6 | 0.010 |
Why?
| Exercise | 1 | 2005 | 125 | 0.010 |
Why?
| Delayed-Action Preparations | 1 | 2002 | 4 | 0.010 |
Why?
| Focus Groups | 1 | 2002 | 13 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|